安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines Join our team and explore clinical trials
- Regeneron Pharmaceuticals - Wikipedia
Regeneron Pharmaceuticals, Inc is an American biotechnology company headquartered in Westchester County, New York The company was founded in 1988 [2]
- Investor Relations | Regeneron Pharmaceuticals Inc.
Interactive and downloadable financial data for investors and analysts We're dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations
- Regeneron Pharmaceuticals, Inc. (REGN) Growth Story Shifts as Wells . . .
On June 10, 2025, Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) received a ‘Hold’ rating from Wells Fargo, which set the company’s stock price target at $580 REGN is one of the 7 52-week
- Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for . . .
23andMe will be operated as a wholly owned direct or indirect subsidiary of Regeneron Pharmaceuticals, Inc and continue operations as a personal genomics service Regeneron’s purchase does not include 23andMe’s Lemonaid Health business Additional details about the company’s operating plans will be shared at time of closing
- REGN - Regeneron Pharmaceuticals Inc News - Morningstar
Read about Regeneron Pharmaceuticals Inc (REGN:XNAS) stock and today's latest news and financial updates
- UBS Lowers Price Target On Regeneron Pharmaceuticals, Inc. (REGN).
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds UBS has maintained its Neutral rating on Regeneron Pharmaceuticals, Inc
- About Regeneron | Our Company - Regeneron Pharmaceuticals
We are a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases
|
|
|